Clinical Trial Update: Safety and Tolerability Study for Age-Related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 safety and tolerability study for neovascular age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Iconic Therapeutics, Inc. | Conditions: Neovascular Age-Related Macular Degeneration | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-11-06